One Step Ahead in Intelligence, Fully Confident in the "Core"!
Recently, at the 2024 China Obesity Week and the Huaxia Metabolic Surgery Forum of the Academic Conference of the Metabolic Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care,MedtronicSignia™Chip Intelligent Anastomosis PlatformThe first stop in China has been grandly launched, marking its official entry into the Chinese market, injecting new vitality into China's surgical field.
Recently, taking advantage of the 4th Thoracic Surgery Focus Symposium and the 28th Thoracoscopy and Minimally Invasive Thoracic Surgery Training Course, the second launch event of the Signia™ Chip Intelligent Stapling Platform's national series was held. Over 600 renowned thoracic surgery experts from across China jointly witnessed the arrival of the chip intelligent stapling era.
At Two Listing Conferences, Industry Experts Gathered to Share the Technical Features, Application Advantages, and Future Development Prospects of the Signia™ Chip Intelligent Stapling Platform. On-Site Experts Highly Praised Medtronic's Excellence in Medical Technology, Product Innovation, and Service Quality, and Expressed Their Expectations for Medtronic to Continue Innovating and Launching More Cutting-Edge Products to Benefit More Patients.
"Innovation-Driven"`, meeting clinical needs`
With the rapid development of China's economy and the intensification of the aging population trend, the demand for surgeries has shown a significant growth. In addition, the current gradual advancement of the tiered medical treatment system and the rapid expansion of the surgery market in secondary hospitals have placed higher demands on the accessibility of quality medical resources.
The stapler plays an important role in the surgical process. Its widespread adoption has spanned half a century, with application scenarios evolving from initial use only in open surgeries to suitability for endoscopic procedures. The mode of operation has also shifted from traditional manual firing that relies on the surgeon's experience to electric firing, further enhancing its stability. However, as medical services continue to advance and surgeries become increasingly complex, variations in patients' physical conditions and comprehensive cancer treatments both impact the characteristics of human tissues, presenting higher challenges for the clinical application of staplers.
With the launch of Medtronic Surgical's groundbreaking product – the Signia™ Stapling System with chip technology, it will drive surgical stapling into the intelligent era, meeting more complex and personalized surgical needs.
Just before the launch of the Signia™ Chip Intelligent Anastomosis Platform, Medtronic's surgical operations department held a series of events and initiated multiple clinical applications across China.
1. Signia™ Chip - Smart Stapler "Inventor" and SCJ Wireless Ultrasonic Scalpel "Pioneer" Tasting Event, Exploring New Product High-Tech, Business Insights, and Market Opportunities
2. Master Experts' Thoracoscopic Lobectomy Clinical Application
3.2024 China Obesity Week: Master's Live Broadcast of Laparoscopic Sleeve Gastrectomy - Clinical Application
4.2024 China Obesity Week - First Stop Launch
5. The 4th Thoracic Surgery Focus Symposium - Second Session Market Launch
Zang Jing, Vice President of Commercial Operations, Surgical Division, Medtronic China
"This year marks the 75th anniversary of Medtronic's global innovation and the 35th anniversary of its presence in China. Medtronic Surgical boasts a long history, a diverse product portfolio, and numerous star products. The Signia™ Stapling System with chip technology, as one of its shining gems, demonstrates Medtronic's excellence in innovation and technology. Moving forward, we will continue to uphold the principles of innovation, collaboration, and win-win cooperation, consistently leading the forefront of medical technology and driving the vigorous development of China’s surgical field. We believe that the launch of Signia™ is just the beginning, and in the future, we will bring more groundbreaking solutions to China’s surgical domain, striving to 'alleviate pain, restore health, and extend life' for patients!"
